SWM
MRK icon

Salvus Wealth Management’s Merck MRK Stock Holding History

Salvus Wealth Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$647K Buy
5,037
+500
+11% +$58.5K 0.36% 72
2026
Q1 		$546K Buy
4,537
+316
+7% +$36.5K 0.32% 78
2025
Q4 		$444K Buy
4,221
+205
+5% +$19.2K 0.25% 87
2025
Q3 		$337K Buy
4,016
+746
+23% +$61.4K 0.19% 103
2025
Q2 		$259K Buy
3,270
+119
+4% +$9.46K 0.15% 107
2025
Q1 		$283K Sell
3,151
-9,386
-75% -$876K 0.18% 102
2024
Q4 		$1.25M Sell
12,537
-2,888
-19% -$298K 0.8% 33
2024
Q3 		$1.75M Buy
15,425
+61
+0.4% +$7.25K 1.08% 30
2024
Q2 		$1.9M Buy
15,364
+96
+0.6% +$12.4K 1.31% 22
2024
Q1 		$2.01M Buy
15,268
+61
+0.4% +$7.52K 1.38% 20
2023
Q4 		$1.66M Sell
15,207
-50
-0.3% -$5.19K 1.18% 24
2023
Q3 		$1.57M Buy
15,257
+366
+2% +$39.4K 1.24% 23
2023
Q2 		$1.72M Buy
14,891
+230
+2% +$26.1K 1.32% 21
2023
Q1 		$1.56M Buy
14,661
+143
+1% +$15.4K 1.26% 22
2022
Q4 		$1.61M Sell
14,518
-64
-0.4% -$6.54K 1.48% 22
2022
Q3 		$1.26M Buy
14,582
+380
+3% +$33.9K 1.2% 24
2022
Q2 		$1.29M Sell
14,202
-162
-1% -$14.4K 1.16% 24
2022
Q1 		$1.18M Buy
14,364
+5,937
+70% +$468K 0.9% 31
2021
Q4 		$646K Buy
8,427
+219
+3% +$17.4K 0.47% 51
2021
Q3 		$617K Buy
8,208
+442
+6% +$33.6K 0.5% 46
2021
Q2 		$606K Buy
7,766
+549
+8% +$40.8K 0.51% 45
2021
Q1 		$520K Buy
7,217
+611
+9% +$45.1K 0.49% 50
2020
Q4 		$523K Buy
+6,606
New +$505K 0.57% 43

Other funds holding MRK

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Salvus Wealth Management's MRK Position: Q2 2026 in Review

Salvus Wealth Management increased its Merck (MRK) stake by 11% in Q2 2026, buying an estimated $58.5K and bringing the position to 5,037 shares worth $647K. The position accounts for 0.36% of the portfolio, ranked #72.

Salvus Wealth Management first reported a position in MRK in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.01M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Salvus Wealth Management held 5,037 shares of Merck worth $647K as of Q2 2026.
  • Salvus Wealth Management bought 500 Merck shares in Q2 2026, an estimated $58.5K.
  • Merck made up 0.36% of Salvus Wealth Management's portfolio in Q2 2026, its #72 holding.
  • Salvus Wealth Management first reported a position in Merck in Q4 2020 and has held it in 23 quarters since.
  • Salvus Wealth Management's Merck position peaked at $2.01M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Salvus Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.